Table 1.
Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | |
---|---|---|---|---|---|---|---|---|
Age | 37 | 51 | 36 | 42 | 32 | 69 | 39 | 32 |
Menopausal status | premenopausal | premenopausal | premenopausal | premenopausal | premenopausal | postmenopausal | premenopausal | premenopausal |
ECOG | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Initial complaint | stomachache | stomachache | stomachache | abdominal swelling | abdominal swelling | stomachache | abdominal swelling | nausea, vomiting |
Pathology of gaster | SRCC | SRCC | SRCC + adenocarcinoma | SRCC | SRCC | adenocarcinoma | SRCC | adenocarcinoma |
Gastric operation | DSG | TG + D2 lymph node dissection | TG+ D2 lymph node dissection | no | no | no | no | DSG |
Stage | 3C (20/3 lymph node) | 3C (13/18 lymph node) | 3A (23/35 lymph node) | 4 | 4 | 4 | 4 | 3A (13/18 lymph node) |
Diagnosis of metastasis | ovarian biopsy | ovarian biopsy | bilateral salpingo-oophorectomy | right salpingo-oophorectomy | ovarian biopsy | right salpingo-oophorectomy | right salpingo-oophorectomy | bilateral salpingo-oophorectomy |
Pathology of ovary | SRCC | SRCC | SRCC | SRCC | SRCC | SRCC | SRCC | SRCC |
Adjuvant chemotherapy | FUFA | FUFA | FUFA | no | no | no | no | FUFA |
Radiotherapy | yes | yes | yes | no | no | no | no | yes |
PFS (month) | 19 | 15 | 25 | 4 | 1 | 7 | 4 | 31 |
First line palliative chemotherapy | DCF | DCF | DCF | carboplatin+ paclitaxel | no | DCF | DCF | DCF |
Time to metastasis or death (months) | 7 | 3 | 4 | 2 | 1 | 1 | 1 | 10 |
OS (months) | 26 | 18 | 29 | 6 | 1 | 8 | 5 | 41 |
Last status | exitus | exitus | exitus | exitus | exitus | exitus | exitus | exitus |
ECOG – Eastern Cooperative Oncology Group, SRCC – signet ring cell carcinoma, PFS – progression-free survival, OS – overall survival, DSG – distal subtotal gastrectomy, TG – total gastrectomy, FUFA – 5-fluorouracil, folinic acid, DCF – docetaxel, cisplatin, 5-fluorouracil